Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators-Reference-Cited by-同舟云学术

Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators

Published:2011-03-01 Issue:3 Volume:96 Page:717-725
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Ayala-Ramirez Montserrat¹,Feng Lei²,Johnson Marcella M.²,Ejaz Shamim¹,Habra Mouhammed Amir¹,Rich Thereasa³,Busaidy Naifa¹,Cote Gilbert J.¹,Perrier Nancy³,Phan Alexandria⁴,Patel Shreyaskumar⁵,Waguespack Steven¹,Jimenez Camilo¹

Affiliation:

1. Department of Endocrine Neoplasia and Hormonal Disorders (M.A.-R., S.E., M.A.H., N.B., G.J.C., S.W., C.J.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030

2. Department of Biostatistics (L.F., M.M.J.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030

3. Department of Surgical Oncology (T.R., N.P.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030

4. Department of Gastrointestinal Medical Oncology (A.P.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030

5. Department of Sarcoma Medical Oncology (S.P.), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/96/3/717/9067949/jcem0717.pdf

Reference40 articles.

1. Malignant pheochromocytoma: current status and initiatives for future progress.;Eisenhofer;Endocr Relat Cancer,2004

2. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.;Gimenez-Roqueplo;Cancer Res,2003

3. Pathology and genetics of tumours of endocrine organs. World Health Organization Classification of Tumours;DeLellis,2004

4. The diagnosis and management of malignant phaeochromocytoma and paraganglioma.;Chrisoulidou;Endocr Relat Cancer,2007

5. Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy.;Nomura;J Clin Endocrinol Metab,2009

Cited by 347 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice;Molecular and Cellular Endocrinology;2024-10

2. Case Report: Unveiling an anomalous diaphragmatic paraganglioma mimicking a hepatic tumor;F1000Research;2024-09-09

3. Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial;European Journal of Cancer;2024-09

4. Weakly supervised detection of pheochromocytomas and paragangliomas in CT using noisy data;Computerized Medical Imaging and Graphics;2024-09

5. Complete Resection of Aorticopulmonary Paraganglioma With Reconstruction in a Pediatric Patient;Annals of Thoracic Surgery Short Reports;2024-09